YEKATERINA GRIGOL: Open Payments
NPI 1558734178 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,611 in 145 payments from 19 companies in 2025. Trend: 2023 $4,538 · 2024 $3,411 · 2025 $3,611
Food & beverage: $3,417Education: $194
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 31 | $900 |
| Janssen Biotech, Inc. | 22 | $571 |
| UCB, Inc. | 16 | $409 |
| Novartis Pharmaceuticals Corporation | 21 | $295 |
| Mallinckrodt Hospital Products Inc. | 9 | $266 |
| ABBVIE INC. | 9 | $207 |
| AstraZeneca Pharmaceuticals LP | 7 | $149 |
| GlaxoSmithKline, LLC. | 9 | $147 |
| Janssen Scientific Affairs, LLC | 1 | $128 |
| E.R. Squibb & Sons, L.L.C. | 3 | $84 |
Products named: TREMFYA, OTEZLA, Bimzelx, ACTHAR, COSENTYX, UPLIZNA, SAPHNELO, BENLYSTA.
Industry payments across FL — which companies pay providers there.
